
Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …
Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …

Pharma supplies firm Biotec Services International has promoted Dr Fiona Withey to the position of chief executive.



 Withey joined the …
Life sciences executive search and interim management firm RSA has increased the size of its offering with three new appointments. …

NHS England has reportedly commissioned a big pharma lobby group to create an influential report, stoking fears that the five-year …

Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …

Roche has been granted an injunction by a court in India to prevent generic manufacturers of its ageing breast cancer …

Doctors in Northern Ireland have Belfast have teamed up with IT specialists to develop a new smartphone app that can …

The germ of an idea, a very good idea. What if the idea could, like a germ, be a contagious …

Medicines wholesaler and trials supplier Pharmarama International has hired Nadia Whittley to be its new chief executive. Prior to joining …

AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …

Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …

Clinical research organisation INC Research has hired Dr Beatrice Setnik from Pfizer to be its vice president of Clinical Pharmacology. …

An ad campaign by Pancreatic Cancer Action has drawn criticism from other charities for ‘pitting’ different types of cancer against …

A former sales representative for US pharma firm Celgene is accusing her old company of promoting two of its key …
Healthcare comms agency GCI Health has grown its London-based team by hiring senior account director Claire Woods, account director Laura …

AstraZeneca is to shed another 550 jobs as its latest corporate restructure takes shape, bringing to 5,600 the number of …

HRA Pharma has been slammed by the PMCPA after breaching six clauses of the ABPI Code of Practice in its …

Sanofi has announced a mixed bag for its full year results as analysts have questioned why its forecasts for the …

Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …